Erbium--169 versus triamcinolone hexacetonide in the treatment of rheumatoid finger joints.

Abstract	Erbium--169 was compared with triamcinolone hexacetonide in the topical treatment of 32 patients suffering from rheumatoid arthritis. Erbium--169 was injected into 83 and triamcinolone hexacetonide into 54 proximal interphalangeal or metacarpophalangeal joints. Both treatments produced alleviation of joint pain and swelling and improvement of grip strength. At every check-up (1--18 months) the percentage of remissions was higher after triamcinolone hexacetonide injection than after erbium--169. The difference was significant at 1, 3, and 6 months.
Authors	A Ruotsi, M Hypén, A Rekonen, M Oka
Journal	Annals of the rheumatic diseases (Ann Rheum Dis) Vol. 38 Issue 1 Pg. 45-7 (Feb 1979) ISSN: 0003-4967 [Print] England
PMID	434946 (Publication Type: Comparative Study, Journal Article)
Chemical References	Radioisotopes Erbium
Topics	Adult Aged Arthritis, Rheumatoid (therapy) Erbium (administration & dosage, therapeutic use) Female Finger Joint Humans Injections, Intra-Articular Male Middle Aged Radioisotopes (therapeutic use) Remission, Spontaneous Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!